www.youtube.com/@SYMENHAZE
www.youtube.com/@Ph1rm1
www.youtube.com/@666KARTELLRecords
Symen & Pharma : DasTape
Prod. by Pharma

Symen feat Pharma - Gestört (Prod. By Pharma)

Symen Feat Pharma - Blutiger Sommer (Prod. By Pharma)

Symen feat Pharma - Kein Rap (Prod. By Pharma)

Symen feat. Pharma - GeisterStunde (prod. by Pharma)

Symen feat Pharma - Teufelswerk (Prod. By Pharma)

Symen feat Pharma - Pedohunter (Prod. By Pharma)

In 2025, we may see radical top-down changes to our healthcare system as new heads of the NIH - National Institutes of Health, HHS - Health and Human Services; the CDC - Center for Disease Control and Prevention. And the FDA - Food and Drug Administration.

How will the heads of these government agencies ignite tech innovation in the healthcare industry?

We’re speaking to many healthcare tech CEOs, scientists, academics to see what they think.

Joining us is Dr. Robert Pearl, who served as CEO of The Permanente Medical Group (Kaiser Permanente), the nation’s largest medical group, for 18 years. During his tenure, he led 12,000 physicians and 43,000 staff, overseeing the nationally acclaimed care of more than 5 million Kaiser Permanente members on the east and west coasts.

Named one of Modern Healthcare’s 50 most influential physician leaders, Pearl is an advocate for the power of integrated, prepaid, technologically advanced and physician-led healthcare delivery. More than 60,000 readers subscribe to his newsletters on healthcare, including his widely read Monthly Musings on American Healthcare.

Pearl is a clinical professor of plastic surgery at Stanford University School of Medicine and a faculty member at the Stanford Graduate School of Business, where he teaches courses on strategy and leadership and lectures on information technology and healthcare policy.


Bambi Francisco Roizen and Dr. Pearl debate how to reduce healthcare costs amid a Trump administration

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the effect of Acting US Food and Drug Administration Commissioner Sara Brenner’s use of MAHA in her introductory memo (:35), the issues that emerged during MAHA founder and Health and Human Services Secretary nominee Robert F. Kennedy Jr.’s Senate confirmation hearings (7:22), return to office plans for senior FDA staff (14:27), and postponed meetings and other impacts of the Trump Administration’s freeze on agency communications (19:30).

More On These Topics From The Pink Sheet

US FDA Acting Commissioner Tells Staff She’s Ready To MAHA: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fda-acting-commissioner-tells-staff-shes-ready-to-maha-D3VJ2JORKVEC5MKJNBRNY2XAOE/ 

Beyond Vaccines: Kennedy’s Anti-Pharma Side On Display At Senate Hearings: https://insights.citeline.com/pink-sheet/agency-leadership/beyond-vaccines-kennedys-anti-pharma-side-on-display-at-senate-hearings-EATXNW5MNBATFDTUWSIDDO6RDA/ 

Will Republican Senator’s Concerns About Kennedy’s Vaccine Views Endanger Nomination?: https://insights.citeline.com/pink-sheet/vaccines/will-republican-senators-concerns-about-kennedys-vaccine-views-endanger-nomination-ZQMM3G6NIFAQ7NPS2WF6F22PFE/ 

Medicare Price Negotiation Will Continue Under Trump With Possible ‘Improvements’: https://insights.citeline.com/pink-sheet/geography/north-america/united-states/medicare-price-negotiation-will-continue-under-trump-with-possible-improvements-BD6JAB25KZDLXO7MCVDCTLEESE/ 

US FDA Senior Staff Return To Office In February, Next Steps for Schedule F Reclassification: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fda-senior-staff-return-to-office-in-february-next-steps-for-schedule-f-reclassification-ETI5TGY5XRACLA76GCYY2PEZ74/ 

US FDA Opioids Adcomm Postponed; Are Communications Freeze, Travel Ban To Blame?: https://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/us-fda-opioids-adcomm-postponed-are-communications-freeze-travel-ban-to-blame-H4WQ4DLAJBD5HOZAWBCSRDBTIA/ 

Approvals The US FDA Is Not Talking About: A Communication Freeze Calendar: https://insights.citeline.com/pink-sheet/product-reviews/approvals-the-us-fda-is-not-talking-about-a-communication-freeze-calendar-DHS4X56LNNFELPXQ6JAZSGJMGA/

Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings

"За кадром" 
Coming soon..

129 PHARMACIST ещё одна New Era

одна затяжка сразу две отдышки
выливаю майку всё у меня словесная отрыжка
меняешь свое мнение как я меняю тишки (часто)
смотрю на реп и вижу как же дешевеет биржа

начиная с 21-го ниче не поменялось 
нажрались фаст фуда чувство голода осталось
нам не нужен мак мы создали свой аналог
смотрю на бифы и смеюсь хотя смешного мало

подсосы раньше были броуки терь подсосы с кэшэм
вас так бесит что я сверху будто бы я чья то плешина
мало кто гонится за сутью много кто за внешностью
каждый фрешмен тут надолго ну конечно же


знай я с того же теста и не буду отрицать 
всегда ебала правда и ебала твоего певца
лига не опасна без интернета и музла
чтобы стало безопасней нужно запретить меня


так больно говорить но молчать ещё больней
я всегда хаа окей
чем ближе мы с тобою от того и нам больней
если сыпишь соль на рану бейби лучше не жалей


может и хуй с ней 
опять новый день
я как чья то тень

да и хуй бы с ней 
я подохну здесь
но лишь бы мне не стать однообразным далбаебом
и не потерять того чего копил все эти годы 

а ты

из года в год одно и тоже ты че блять принтер
одни и те же оппы с разбавленным лином
зато пиздеть умеют лихо и планов было как население России 
с совокупности с остальным миром


129 моя семья не были просто цифры
других ненавижу либо нас не любят трижды
перед сном ебу мозги создавая себе блиц
чтобы выяснить в дальнейшем где илья где PHARMACIST

PHARMACIST- Игра не стоит свеч

Introduction: Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the many commitments Robert F. Kennedy Jr. gave Sen. Bill Cassidy, R-LA, to secure his vote to move his Health and Human Services Secretary nomination to the Senate floor (:25). They also consider the slow restoration of some US Food and Drug Administration public communications and the impact of HHS postponing activities not deemed “mission-critical” (10:36).

More On These Topics From The Pink Sheet

HHS Nominee Kennedy’s Behind-The-Scenes Vaccine Reassurances Win Senate Swing Vote: https://insights.citeline.com/pink-sheet/vaccines/hhs-nominee-kennedys-behind-the-scenes-vaccine-reassurances-win-senate-swing-vote-F45HDCJQJJDIDKJOFXYODP6DJQ/ 

Kennedy Would Issue Trial Diversity Guidance, But Not Necessarily Roll Back All Anti-DEI Actions: https://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/diversity-and-inclusion/kennedy-would-issue-trial-diversity-guidance-but-not-necessarily-roll-back-all-anti-dei-actions-4SDSMJ5V7NFPHKVUX5XYBMRMEE/ 

FDA Communications In Flux As HHS Assesses Mission-Critical Activities: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/fda-communications-in-flux-as-hhs-assesses-mission-critical-activities-H5UQ7BRSSZBVJDJBAXSVTDLIR4/ 

As US FDA Communications Freeze Thaws, Approvals Accumulate: https://insights.citeline.com/pink-sheet/product-reviews/approvals/as-us-fda-communications-freeze-thaws-approvals-accumulate-JA4WVLHMGJEZDHYB7LRNZAOYT4/ 

Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Нести хуйню всякую это моя специализация

New tracks tagged #pharma